Enfermedades inflamatorias y neoplásicas del tracto gastrointestinal, enfermedades hepáticas prevalentes
ENGASTRO
Instituto Ramón y Cajal de Investigación Sanitaria
Madrid, EspañaPublicacións en colaboración con investigadores/as de Instituto Ramón y Cajal de Investigación Sanitaria (3)
2024
-
Longitudinal outcomes of obeticholic acid therapy in ursodiol-nonresponsive primary biliary cholangitis: Stratifying the impact of add-on fibrates in real-world practice
Alimentary Pharmacology and Therapeutics
-
Real-life effectiveness of sofosbuvir/velpatasvir/voxilaprevir in hepatitis C patients previously treated with sofosbuvir/velpatasvir or glecaprevir/pibrentasvir
Alimentary Pharmacology and Therapeutics
2016
-
Addition of Simvastatin to Standard Therapy for the Prevention of Variceal Rebleeding Does Not Reduce Rebleeding but Increases Survival in Patients with Cirrhosis
Gastroenterology, Vol. 150, Núm. 5, pp. 1160-1170.e3